| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc1a743e3ea4fc41c482ac2a8f5620b6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2021-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6ddfc2a3ebeed24ba59b4c48e455ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b1691b74396891f7610cca7a3dab34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d194b1559398776824c358dab32b74ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_785ebffd77b480022f5ce01d88fdaa29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edca6117354e7d0391d6e06bc5c6abe5 |
| publicationDate |
2021-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021388052-A1 |
| titleOfInvention |
Tmigd2 and its derivatives as blockers or binders of cancer-expressed hhla2 for immunotherapies |
| abstract |
Provided are methods of treating an HHLA2-bearing tumor in a subject with a fusion protein comprising an IgV-like domain of a TMIGD2 sufficient to treat the HHLA2-bearing tumor. A fusion protein comprising an IgV-like domain of a TMIGD2 and related compositions and encoding nucleic acids are also provided. |
| priorityDate |
2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |